«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

29卷

期数:

2023年04期

页码:

427-431

栏目:

临床医学

出版日期:

2023-07-10

文章信息/Info

Title:

Virulence gene carrying of Acinetobacter baumannii in lower respiratory tract infection and its correlation with prognosis

文章编号:

1006-8147（2023）04-0427-05

作者:

曹源; 崔晓慧; 梁歌宏; 李洪钧; 张欣蕊; 王悦

天津医科大学第二医院风湿免疫科，天津300211

Author(s):

CAO Yuan; CUI Xiao-hui; LIANG Ge-hong; LI Hong-jun; ZHANG XIN-rui; WANG Yue

Department of Rheumatology and Immunology，The Second Hospital，Tianjin Medical University，Tianjin 300211，China

关键词:

鲍曼不动杆菌; 下呼吸道感染; 毒力基因; 耐药性; 预后

Keywords:

Acinetobacter baumannii; lower respiratory tract infection; virulence gene; drug resistance; prognosis

分类号:

R563

DOI:

-

文献标志码:

A

摘要:

目的：了解临床下呼吸道来源标本分离鲍曼不动杆菌的毒力基因与耐药性及预后的关系。方法：收集2021年6月—2022年9月天津医科大学第二医院住院患者下呼吸道来源标本分离的鲍曼不动杆菌219株，PCR扩增以下毒力基因：外膜蛋白A（ompA）、生物膜相关蛋白（bap）、血红素加氧酶（hemO）、群体感应系统组成基因abaI和abaR。收集相关炎症指标、药敏结果和患者预后信息。结果：219株鲍曼不动杆菌毒力基因ompA、bap、hemO、abaI、abaR的总体携带率分别为83.11%、57.53%、47.49%、69.41%、64.84%。多重耐药鲍曼不动杆菌（MDR-AB）毒力基因ompA、bap、abaI、abaR携带率高于非多重耐药鲍曼不动杆菌（NMDR-AB）（χ2=27.186、69.044、53.067、68.763，均P＜0.01），而hemO的携带率与此相反（χ2=5.366，P＜0.05）；Spearman相关性分析显示，ompA、bap、abaI、abaR的携带率与预后呈正相关（r=0.197、0.303、0.294、0.292，均P＜0.01），且预后不良组菌株同时携带的毒力基因数量也更多。白细胞升高组bap和abaR的携带率更高（χ2=6.517、4.977，均P＜0.05）、C反应蛋白升高组ompA和abaR的携带率更高（χ2=7.478、6.405，均P＜0.05）、PCT升高组abaI的携带率更高（χ2=5.082，P＜0.05）。结论：下呼吸道标本来源鲍曼不动杆菌普遍携带多种毒力基因，多重耐药株的毒力基因携带率更高，毒力基因携带与患者预后有一定相关性。

Abstract:

Objective：To investigate the relationship between virulence genes，drug resistance and prognosis of Acinetobacter baumannii isolated from clinical specimens of lower respiratory tract. Methods：A total of 219 strains of Acinetobacter baumannii isolated from lower respiratory tract samples of hospitalized patients at Tianjin Medical University Second Hospital from June 2021 to September 2022 were collected，and the following virulence genes were amplified by PCR：Outer membrane protein A（ ompA），biofilm-associated protein （ bap），Heme oxygenase （ hemO），quorum sensing system component genes abaI and abaR. Relevant inflammatory indicators，drug sensitivity results and patient prognosis information were collected. Results：The overall carrying rates of virulence genes ompA，bap， hemO，abaI and abaR of 219 strains were 83.11%，57.53%，47.49%，69.41% and 64.84%，respectively. The carrying rates of virulence genes ompA，bap，abaI and abaR in multidrug-resistant Acinetobacter Baumannii （ MDR-AB） were higher than those in non-multidrug-resistant Acinetobacter Baumannii（ NMDR-AB）（ χ2=27.186，69.044，53.067，68.763，all P<0.01）. The carrying rate of hemO was on the contrary （ χ2=5.366，P<0.05）. Spearman correlation analysis showed that the carrying rate of ompA，bap，abaI and abaR were positively correlated with the prognosis （ r = 0.197，0.303，0.294，0.292，all P<0.01），and the number of virulence genes carried by the strains in the poor prognosis group was also higher. The carrying rates of bap and abaR were higher in the increased WBC group （ χ2=6.517，4.977，both P<0.05），the carrying rates of ompA and abaR were higher in the increased CRP group（ χ2=7.478，6.405，P<0.05）， and the carrying rates of abaI were higher in the increased PCT group（ χ2=5.082，P<0.05）. Conclusion：Acinetobacter baumannii from lower respiratory tract specimens generally carries multiple virulence genes，and the multidrug-resistant strains have a higher virulence gene carrying rate，and virulence gene carrying has a certain correlation with the prognosis of patients.

参考文献/References:

[1] HARDING C M，HENNON S W，FELDMAN M F. Uncovering the mechanisms of Acinetobacter baumannii virulence[J]. Nat Rev Mi－crobiol，2018，16（ 2）：91-102.
[2] WORLD HEALTH ORGANIZATION. Guidelines for the prevention and control of carbapenem-resistant enterobacteriaceae，Acineto－bacter baumannii and pseudomonas aeruginosa in health care facili－ties[R]. Gevena：WHO，2017：1-76.
[3] 胡付品，郭燕，周德妹，等. 2021年CHINET中国细菌耐药监测[J].中国感染与化疗杂志，2022，22（ 5）：521-530.
[4] CHEN W. Host-pathogen interactions in Acinetobacter baumannii infection：recent advances and future challenges[J]. Future Microbi－ol，2020，15：841-845.
[5] MORRIS F C，DEXTER C，KOSTOULIAS X，et al. The mechanisms ofdiseasecausedbyAcinetobacterbaumannii[J].FrontMicrobiol，2019， 10：1601.
[6] 陈佰义，何礼贤，胡必杰，等.中国鲍曼不动杆菌感染诊治与防控专家共识[J].中华医学杂志，2012（ 2）：76-85.
[7] 孙康，潘蕾，金发光.多重耐药鲍曼不动杆菌肺炎治疗进展[J].中华结核和呼吸杂志，2021，44（ 6）：582-587.
[8] FOULDS J，CHAI T J. Defeat of colicin tolerance in Escherichia coli ompA mutants：evidence for interaction between colicin L-JF246 and the cytoplasmic membrane[J]. J Bacteriol，1978，133（ 1）：158-164.
[9] TIKU V，KOFOED E M，YAN D，et al. Outer membrane vesicles containing OmpA induce mitochondrial fragmentation to promote pathogenesisofAcinetobacter baumannii[J].SciRep，2021，11（1）：618.
[10] NIE D，HU Y，CHEN Z，et al. Outer membrane protein A（OmpA）as a potential therapeutic target for Acinetobacter baumannii infection [J]. J Biomed Sci，2020，27（ 1）：26.
[11] MUHAMMAD M H，IDRIS A L，FAN X，et al. Beyond risk：bacterial biofilms and their regulating approaches[J]. Front Microbiol，2020， 11：928.
[12] BROSSARD K A，CAMPAGNARI A A. The Acinetobacter bauman－nii biofilm-associated protein plays a role in adherence to human epithelial cells[J]. Infect Immun，2012，80（ 1）：228-233.
[13] BATEMAN T J，SHAH M，HO T P，et al. A Slam-dependent hemophore contributes to heme acquisition in the bacterial pathogen Acinetobacter baumannii[J]. Nat Commun，2021，12（ 1）：6270.
[14] GIARDINA B J，SHAHZAD S，HUANG W，et al. Heme uptake and utilization by hypervirulent Acinetobacter baumannii LAC-4 is de－pendent on a canonical heme oxygenase（abHemO）[J]. Arch Biochem Biophys，2019，672：108066.
[15] SAIPRIYA K，SWATHI C H，RATNAKAR K S，et al. Quorum-sens－ing system in Acinetobacter baumannii：a potential target for new drug development[J]. J Appl Microbiol，2020，128（ 1）：15-27.
[16] STACY D M，WELSH M A，RATHER P N，et al. Attenuation of quo－rum sensing in the pathogen Acinetobacter baumannii using non-native N-Acyl homoserine lactones[J]. ACS Chem Biol，2012，7（10）：1719-1728.
[17] KONGTHAI P，THUMMEEPAK R，LEUNGTONGKAM U，et al. In－sight into molecular epidemiology，antimicrobial resistance，and vir－ulence genes of extensively drug-resistant Acinetobacter baumannii in Thailand[J]. Microb Drug Resist，2021，27（ 3）：350-359.
[18] YANG C H，SU P W，MOI S H，et al. Biofilm formation in Acineto－bacter baumannii：genotype-phenotype correlation [J]. Molecules， 2019，24（ 10）：1849.
[19] MELLMAN I. Dendritic cells：master regulators of the immune re－sponse[J]. Cancer Immunol Res，2013，1（ 3）：145-149.
[20] ABDI H A，HORMOZI B，NAJIMI M，et al. High prevalence of iron acquisition genes among Acinetobacter baumannii strains isolated from patients with urinary tract infections in southeast of Iran [J]. Avicenna J Clin Microbiol Infect，2015，2（ 4）：30656-30656.
[21] PORBARAN M，TAHMASEBI H，ARABESTANI M. A Comprehen－sive study of the relationship between the production of β-lactamase enzymes and iron/siderophore uptake regulatory genes in clinical isolates of Acinetobacter baumannii[J]. Int J Microbiol，2021，2021：5565537.
[22] THUMMEEPAK R，KONGTHAI P，LEUNGTONGKAM U，et al. Distribution of virulence genes involved in biofilm formation in mul－ti-drug resistant Acinetobacter baumannii clinical isolates [J]. Int Microbiol，2016，19（ 2）：121-129.
[23]唐婕.鲍曼不动杆菌临床株耐药、毒力特征及其与Abal/AbaR群体感应系统相关性研究[D].吉林：吉林大学，2019.
[24] KIM M，PARK J，PARK W. Genomic and phenotypic analyses of multidrug-resistant Acinetobacter baumannii NCCP 16007 isolated from a patient with a urinary tract infection[J]. Virulence，2021，12（1）：150-164.
[25] BAI B，EALES B M，HUANG W，et al. Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by Acinetobacter baumannii[J]. Virulence，2022，13（ 1）：1920-1927.
[26] WONG D，NIELSEN T B，BONOMO R A，et al. Clinical and patho－physiological overview of acinetobacter infections：a century of chal－lenges[J]. Clin Microbiol Rev，2017，30（ 1）：409-447.
[27] GAO Y，LIN H，XU Y，et al. Prognostic risk factors of carbapenem-resistant gram-negative bacteria bloodstream infection in immuno－suppressed patients：a 7-year retrospective cohort study [J]. Infect Drug Resist，2022，15：6451-6462.
[28] LAW S K K，TAN H S. The role of quorum sensing，biofilm forma－tion，and iron acquisition as key virulence mechanisms in Acineto－bacter baumannii and the corresponding anti-virulence strategies[J]. Microbiol Res，2022，260：127032.

相似文献/References:

[1]文晓龙,权 伟,江荣才.神经外科重症监护室中脑外伤感染泛耐药鲍曼不动杆菌12例分析[J].天津医科大学学报,2015,21(03):255.
[2]余 倩,胡志东,李 静,等.3种方法评估肺炎克雷伯菌及鲍曼不动杆菌对替加环素的体外药敏结果分析[J].天津医科大学学报,2015,21(06):510.
　YU Qian,HU Zhi-dong,LI Jing,et al.Effect of Tigecycline on Klebsiella pneumoniae and Acinetobacter baumanaii by susecptibility testing in vitro[J].Journal of Tianjin Medical University,2015,21(04):510.
[3]张 燕,何新飙.ICU患者感染鲍曼不动杆菌的危险因素及耐药性分析[J].天津医科大学学报,2016,22(04):318.
　ZHANG Yan,HE Xin-biao.Analysis of risk factors and drug resistance of the patients fected with Acinetobater baumanii in intensive care unit[J].Journal of Tianjin Medical University,2016,22(04):318.
[4]翟慧群,班 博.鲍曼不动杆菌感染对气管插管患者预后的影响[J].天津医科大学学报,2016,22(04):335.
[5]包佳婷,王勇强,王 兵,等.2014-2017年我院鲍曼不动杆菌分布及ICU内鲍曼不动杆菌耐药性分析[J].天津医科大学学报,2019,25(06):600.
　BAO Jia-ting,WANG Yong-qiang,WANG Bing,et al.Analysis on the distribution of Acinetobacter baumannii in our hospital and the drug resistance of Acinetobacter baumannii in ICU from 2014 to 2017[J].Journal of Tianjin Medical University,2019,25(04):600.
[6]孔海芳,胡志东.碳青霉烯耐药鲍曼不动杆菌的临床特征及克隆变迁[J].天津医科大学学报,2020,26(05):471.
　KONG Hai-fang,HU Zhi-dong.Clinical characteristics and clonal dynamics of carbapenem-resistant Acinetobacter baumannii infections[J].Journal of Tianjin Medical University,2020,26(04):471.

备注/Memo

备注/Memo:

基金项目:天津市科技计划项目（21KPXMRC00100）
作者简介:曹源（1997-），女，硕士在读，研究方向：细菌耐药及致病机制；
通信作者：王悦，E-mail：wangyueyd2y@tmu.edu.cn。

常用功能

更新日期/Last Update: 2023-07-10